GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr | ₹773 Cr |
What is the latest Consolidated Net Profit of GLAND PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹781 Cr |
Mar2023 | ₹1,212 Cr |
Mar2022 | ₹997 Cr |
Mar2021 | ₹773 Cr |
Mar2020 | ₹773 Cr |
How is Consolidated Net Profit of GLAND PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹781 Cr | -35.54 | |
Mar2023 | ₹1,212 Cr | 21.54 | |
Mar2022 | ₹997 Cr | 29.00 | |
Mar2021 | ₹773 Cr | 0.00 | |
Mar2020 | ₹773 Cr | - |
Compare Consolidated Net Profit of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹32,973.2 Cr | 5.9% | 17.1% | -2.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 5.9% |
17.1% |
-2.2% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses